Transforming health through research

Cancer patient first in Canada to be treated with a rare radioisotope 


A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with neuroendocrine tumours – a rare form of cancer – using a radioisotope called actinium-225 DOTATATE.

London Health Sciences Centre Research Institute drives forward medical breakthroughs that transform health for children and adults around the world.


As the research institute of London Health Sciences Centre, our teams conduct research where patient care is delivered, working alongside patients, families, health-care providers, and academic partners like Western University.
Dr. Laidley in front of scan images on a computer.
Staff views ROSA robot monitor in clinical space

Research Programs

Our researchers are leaders in advancing the understanding, diagnosis, treatment and management of multiple diseases and health conditions. Our research aligns directly to care programs and clinical expertise at London Health Sciences Centre (LHSC).
Cancer
Cardiology and Vascular Diseases  
Children’s Health
Critical Illness  
Imaging
Mental Health 
Nephrology 
Neurological Disorders  
Orthopaedics  
Personalized Medicine 
Surgery 
Transplantation 
Women’s Health and Obstetrics  
Patient laying in bed with testing cap in Dr Rishi Ganesan lab

Children’s Health Research Institute

Children’s Health Research Institute (CHRI), a program of LHSCRI, discovers ways to prevent and treat diseases affecting babies, children and youth, helping them lead happy, healthy lives.